Building Self-regulation Capacity in AA T2DM Women: Feasibility of EMI
Terminated · Not applicable · NCT04083248
Conditions: Type 2 Diabetes, Self-regulation
At a glance
- Research payments reported, 2025
- $750
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 11
About the trial
- Sponsor
- University of Illinois Chicago (with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Chicago)
- Tested
- Feasibility group (behavioral)
- Dates
- Started 2019-09-20; completion 2020-07-31
- Results posted
- Not yet
In African-Americans, the incidence of type 2 diabetes (T2DM) is \~14%. Adherence to crucial diabetes self-management (DSM) behaviors, such as engaging in physical activity (PA) is dangerously low among AA women living in disadvantaged neighborhoods. These women manage numerous chronic challenges (daily discrimination, poverty, and violence), which drain the internal energy needed for DSM. The ability to self-regulate (modify one's behaviors based on the requirements of a situation) has been associated with adherence to health behaviors, including diet and PA. This 6-week ecological momentary intervention (EMI) feasibility study has been developed to reduce energy needs of DSM through use…
From ClinicalTrials.gov, last updated 2021-05-03. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Ipsen Bioscience Inc. reported $750 in research payments for this study in 2025 (1 payments).
Products named: Onivyde
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- West Clinic Pharmacy $750
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.